Company Filing History:
Years Active: 2010
Title: Eleonora Moin-Kotliar: Innovator in Pharmaceutical Formulations
Introduction
Eleonora Moin-Kotliar is a prominent inventor based in Herzlia, Israel. She has made significant contributions to the field of pharmaceutical formulations, particularly focusing on aliphatic amine polymers. Her innovative work has led to the development of a patent that enhances the stability and efficacy of pharmaceutical compositions.
Latest Patents
Moin-Kotliar holds a patent for "Pharmaceutical formulations of aliphatic amine polymers and methods for their manufacture." This invention provides pharmaceutical compositions that include aliphatic amine polymers, such as Sevelamer HCl, as the active pharmaceutical ingredient. The unique aspect of her invention is the spray granulation method used to prepare stable pharmaceutical compositions, preferably in tablet dosage forms.
Career Highlights
Eleonora Moin-Kotliar is associated with Teva Pharmaceutical Industries Limited, a leading global pharmaceutical company. Her work at Teva has allowed her to focus on innovative solutions in drug formulation, contributing to the advancement of pharmaceutical sciences.
Collaborations
Moin-Kotliar has collaborated with notable colleagues, including Julia Hrakovsky and Ruth Tenengauzer. These collaborations have fostered a creative environment that encourages the development of groundbreaking pharmaceutical technologies.
Conclusion
Eleonora Moin-Kotliar's contributions to pharmaceutical formulations exemplify her dedication to innovation in the field. Her patent on aliphatic amine polymers showcases her ability to enhance drug stability and efficacy. Her work continues to impact the pharmaceutical industry positively.